Last reviewed · How we verify
Not for treatment of type 1 diabetes mellitus
Approved treatments
- Prandin · Novo Nordisk
Repaglinide lowers blood glucose levels by stimulating insulin release from the pancreas through ATP-dependent potassium channel blockade.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Not for treatment of type 1 diabetes mellitus patent landscape — cliff calendar, originator estates, attackable patents
- Not for treatment of type 1 diabetes mellitus treatment landscape brief
- Not for treatment of type 1 diabetes mellitus treatment updates RSS
Frequently asked questions about Not for treatment of type 1 diabetes mellitus
What drugs treat Not for treatment of type 1 diabetes mellitus?
Tracked treatments include Prandin.
What is the treatment for Not for treatment of type 1 diabetes mellitus?
Standard treatment for Not for treatment of type 1 diabetes mellitus includes Prandin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Not for treatment of type 1 diabetes mellitus patent cliff · Not for treatment of type 1 diabetes mellitus CI report
- Treatment: Prandin · Novo Nordisk
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing